Doseranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes - Rosenstock, J; Aggarwal, N; Polidori, D (Diabetes Care, 2012)
et al.